Focus anche sul trattamento innovativo e riabilitativo
Risultati per: Studio chiarisce come l’Alzheimer si diffonde nel cervello
Questo è quello che abbiamo trovato per te
L’elettrocardiogramma nello studio di medicina generale
Antibiotici a neonati, al via studio per prevenire uso improprio
UniCamillus, oggi 99,6% dei piccoli trattato nel modo sbagliato
Gli indicatori di un cervello che invecchia
Ok Ue a farmaco anti-Alzheimer, il primo a rallentare malattia
Neurologi: ‘si apre una nuova storia per i pazienti’
Tumori al cervello, 9 bambini stanno meglio con le Car-T, per uno scomparsa la massa
In California una sperimentazione clinica contro una forma considerata letale. Per uno scomparsa la massa
Abstract 4147625: Cardiometabolic Syndrome and Incident Alzheimer’s Disease: The Predicative Value of Age and CMS Using Cox and Machine Learning Models
Circulation, Volume 150, Issue Suppl_1, Page A4147625-A4147625, November 12, 2024. Background:Cardiometabolic syndrome (CMS) poses a significant public health concern. The study aimed to investigate the predictive value of age and CMS for incident Alzheimer’s disease (AD) in women aged≥50.Methods:A cohort of women aged 50-79 (n= 63,117) who participated in the Women’s Health Initiative Observational Study (WHIOS) in 1993-1998, without baseline AD and followed through to March 1, 2019, were analyzed. CMS was defined as having ≥3 of five CMS components: large waist circumference, HBP, elevated triglycerides, elevated glucose, and low HDL-cholesterol. AD was classified by physician-diagnoses of incident AD. Hazards ratios (HR) of AD risk associated with CMS by age were analyzed using Cox’s proportional hazards regression analysis. Machine learning (ML)-XGBoost and Lasso Cox models clustered individuals with low, mild, moderate, and severe risk of incident AD.Results:During a median follow-up of 20 years (range: 3.36 to 23.36 years), 8340 developed incident AD. The incident rate (95%CI) of AD was 8.6 (8.1-9.1) per 1000 person-years (PY) in women with CMS, and 7.0 (6.9-7.2) per 1000 PY in those without CMS (p
Abstract 4136600: Hypertensive disorders of pregnancy and the risk of Dementia, Alzheimer’s disease, and Vascular Dementia. A Systematic review and Meta-analysis of 25,03,538 women participants.
Circulation, Volume 150, Issue Suppl_1, Page A4136600-A4136600, November 12, 2024. Background:Hypertensive disorders of pregnancy (HDP) are associated with maternal adverse cardiovascular outcomes. However, their association with maternal Dementia and Alzheimer’s disease is not well established with limited and conflicting results to date.Objective:We sought to evaluate the association between HDP and risk of incidence of Dementia, and Alzheimer’s disease.Methods:We performed a systematic review and meta-analysis of available literature that enrolled women with HDP and women without HDP groups. PubMed, Embase and ClinicalTrials.gov were systematically searched from inspection till May 2024 without any language restrictions. Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) were pooled using a random-effect model.Results:A total of 8 studies with 2503538 patients (1,51,905 in women with HDP and 23,51,633 in the women without HDP group) were included. Pooled analysis shows that HDP women were having 37% higher risk of dementia (aHR, 1.37(95%CI: 1.27-1.46), P
Riviste le linee guida diagnostiche per l’Alzheimer
Alzheimer, vari tipi di vaccini abbassano i rischi anche del 30-40%
Aiutano a ‘ripulire’ accumuli tossici nel cervello
Alzheimer, una pdl per riconoscere e tutelare i caregiver
Lions italiani hanno contribuito a proposta con gruppo di lavoro
Uno studio per superare la farmaco resistenza nel tumore al seno
Ricerca del Cro di Aviano pubblicata sul Journal of Pathology
Uno studio per superare la farmaco resistenza nel tumore al seno
Ricerca del Cro di Aviano pubblicata sul Journal of Pathology
APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer’s Disease
New England Journal of Medicine, Volume 391, Issue 17, Page 1660-1661, October 31, 2024.
Una neuroscienziata fa 75 risonanze, così il cervello cambia con la pillola
La corteccia si riduce dell’1%, ma succede anche in pubertà e gravidanza
Pazienti a Meloni, l'Alzheimer sia una priorità per la politica
Affette 1,5 milioni di persone e numero è destinato ad aumentare